A Healthcare-Focused Venture
Helicase Venture is an early-stage firm focused on healthcare. We look to invest in visionary teams and cutting edge technologies in both life science and digital health solutions.
Our philosophy is not to take a one-size-fits-all approach to investing. We draw from our domain expertise and diversified experiences across the full healthcare spectrum to cover both Biopharma, and Digital Health sectors. Our aim is to support companies that can achieve differentiated therapeutic results through truly novel approaches. Combining scientific rigor and strategic connections within our network, we provide guidance and add value to our portfolio companies as they grow.
We invest in companies founded by scientist, industry entrepreneurs and academics.
Therapeutics, Digital Health, AI-Powered Drug Discovery, Diagnostics
All approaches such as small molecule, biologic, cell and gene therapies, etc.
We look for sound scientific principles and we seek innovative approaches, including breakthrough medicines and platform technologies. Our key areas of interest include neurological diseases, metabolic diseases, and infectious diseases.
We make initial investment at varying stages, from seed capital through early clinical development. Our investment team engages with entrepreneurs and companies from early pre-clinical development where there is compelling science with cell and/or animal model proof of concept data and invests through pre-clinical and early clinical proof of concept stages.
Digital health is transformational area in healthcare. We look for technology platforms that enable pertinent scientific insights into drug development and design or enhanced delivery of care from providers to patients. Key areas of interest include synthetic biology, machine learning for drug discovery (proteomics and metabolomics), and tools that help reduce healthcare costs.